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An abundance of data unequivocally shows that exercise can be an effective tool in 
the fight against obesity and its associated co-morbidities.(1) Indeed, physical activity 
can be more effective than widely-used pharmaceutical interventions. Whilst 
metformin reduces the incidence of diabetes by 31% (as compared with a placebo) in 
both men and women across different racial and ethnic groups, lifestyle intervention 
(including exercise) reduces the incidence by 58%. (2) 
 
In this context, it is notable that a group of prominent medics and exercise scientists 
recently sent a well-publicised letter to the General Medical Council and Medical 
Schools Council calling for the introduction of evidence-based lifestyle education into 
all medical curricula(3). The letter warns that there is a lack of understanding of the 
impact that exercise and nutrition can have on physical health amongst doctors. In the 
absence of an educational overhaul, the signatories warn that the government is likely 
to fail to reach its goal of preventing tens of thousands of premature deaths from heart 
disease and cancer by 2020.  
 
Whilst we agree with the need to address this apparent lack of understanding, the 
ethical justification of doing so is not limited to this broadly beneficence-based 
justification. There is also a justification grounded in the duty of non-maleficence, 
that is, the duty to avoid unreasonably harming patients. 
 
Despite the well-established long-term beneficial effects of exercise, the risk of an 
acute cardiovascular event may be transiently elevated during, and just after vigorous 
physical exertion for susceptible individuals. This is the so-called ‘paradox of 
exercise’.(4) This does not mean doctors should refrain from prescribing exercise; the 
long-term beneficial effects of exercise far outweigh the acute risks.(5) Indeed, low 
levels of physical activity are a significant contributing factor to whether a particular 
individual is susceptible to the elevated risk of sudden death during exercise. This risk 
is dramatically lower in regular exercisers, and dramatically higher in habitually 
sedentary individuals who undertake a sudden bout of vigorous exercise.(6) However, 
doctors have a moral reason, grounded in the duty of non-maleficence (that is, the 
duty to not harm patients) to refrain from (i) preventing patients from undergoing 
beneficial treatment without good reason, (ii) exposing patients to unreasonable risks 
(we define Reasonable Risk in Box 1), and (iii) reducing the therapeutic effect of an 
effective medical intervention. This requires an understanding of the physical impact 
of exercise. 
  
 
 
 
 
 
 
 
  
Although doctors have the necessary expertise to identify conventional medical risk 
factors for cardiac events during exercise, a lack of understanding of the physical 
impact of exercise might lead doctors to over-emphasise these risk factors. Under the 
recently updated American College of Sports Medicine (ACSM) exercise pre-
participation health screening process, medical clearance is only recommended for 
exercise if the individual has already been identified as at risk of an acute 
cardiovascular event based on pre-exercise risk factor screening.(7) According to 
these guidelines, whether or not an individual should receive medical clearance prior 
to exercise depends on the individual’s history of physical activity, and the 
individual’s desired exercise intensity (as well as the presence of signs or symptoms 
of known cardiovascular, metabolic, or renal disease).(7) A lack of understanding of 
the importance of these other risk factors might lead doctors to either under-prescribe 
exercise for patients with known cardiovascular, metabolic, or renal disease, or 
dissuade them from exercise by insisting on tests prior to exercise, tests that the 
scientific community has agreed are unnecessary.(7)  
 
Second, we cannot ignore the possibility that this lack of understanding might lead 
doctors to unnecessarily prescribe exercise interventions with a higher degree of 
relative risk. The NHS guidelines for physical activity in adults recommend at least 
150 minutes of moderate aerobic activity for adults per week. This recommendation is 
well-supported and well-established. However, these guidelines also advocate the 
heuristic that ‘one minute of vigorous activity provides the same health benefits as 
two minutes of moderate activity”(8). Yet, for habitually inactive patients, the 
relevant trade-off here is not just between exercising for 10 minutes vs. 20 minutes to 
achieve the same health outcome – it is also a choice between interventions that 
expose these individuals to significantly different degrees of relative risk of suffering 
a cardiac event in trying to achieve the same health outcome. Yet, this higher relative 
risk for inactive individuals can easily be avoided by a gradual progression toward 
vigorous exercise.(9) In view of the definition provided in Box 1, in particular factors 
1 and 3, this may constitute exposing patients to unreasonable risk. Recognizing this 
is all the more important following the Montgomery Ruling governing claims of 
medical negligence: doctors need to be increasingly aware of even small risks of 
medical interventions, the potential need to disclose these risks, and to offer 
alternatives when possible.  
 
 
Box 1. Reasonable Risk 
 
In determining whether the risks of participation in exercise are reasonable, the following factors are relevant 
(based on [10,11]) 
 
1. Is there a known risk to participants prior to commencing exercise and what is its magnitude, based on 
evidence available at the time? Are there relevant evidence-based professional guidelines (e.g. ACSM 
guidelines) to categorise the risk to this participant? 
 
2. Should any further research (e.g. systematic overview or computer modelling) be performed prior to the 
exercise to better estimate the risk to particular participants? 
 
3. Could the risk be reduced in any other way? Is it as small as possible? 
 
4. Are the potential benefits (in terms of health and global well-being) of exercise worth the risks? 
 
Finally, a lack of understanding of the interactions between pharmaceuticals and 
exercise could lead doctors to prescribe treatments that are not only less effective than 
exercise, but which might serve to blunt its therapeutic effect. A recent study suggests 
that metformin might serve to attenuate the effects of exercise on certain 
cardiovascular risk factors and the severity of metabolic syndrome in patients with 
impaired glucose tolerance.(12) Even more strikingly in this context, some statins 
may attenuate the exercise-mediated increases in cardio-respiratory fitness in obese or 
overweight patients.(13) Further large-scale studies are required to confirm the 
relationship between these medications and the exercise intervention outcomes.  
However, these studies raise the possibility that prescribing these drugs rather than 
exercise for certain patients might not simply mean foregoing the benefit of a more 
effective treatment; if the patient has already adopted lifestyle changes to combat their 
disease, these drugs might reduce the considerable therapeutic effect of these lifestyle 
changes.  
 
Exercise prescription can be a powerful weapon in the fight against obesity and its 
associated co-morbidities. However, in order to maximise the therapeutic benefits of 
exercise, and to avoid the unnecessary harms outlined above, it must be implemented 
by professionals with an adequate understanding of the impact that exercise can have 
on physical health. If doctors are expected to be at the vanguard of exercise 
prescription, and assuming they can be said to apparently lack the aforementioned 
understanding, our arguments lend support to the conclusions reached in the recent 
letter sent to the GMC. However, we also note that there will be significant costs 
associated with overhauling medical education in the way that the signatories of the 
letter advocate, and that doctors are already highly over-burdened in the UK. As such, 
our arguments may also be taken to highlight the crucial importance of considering 
alternative ways in which it may be possible to bring existing expertise regarding the 
impact of exercise on physical health to bear at the coal-face in medicine. 
Professionals with training in exercise medicine and under the governance of the 
Faculty of Sport and Exercise Medicine UK would be well-placed to fill this lacuna, 
in light of their grasp of the relevant evidence and guidelines, and their ability to 
assess reasonable risk in this context. 
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